Jae Park, MD, Memorial Sloan Kettering Cancer Center
Advertisement
Articles by Jae Park, MD, Memorial Sloan Kettering Cancer Center
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma
2
FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC
3
Zoldonrasib Combinations Show Compelling Antitumor Activity in RAS G12D–Mutant Metastatic PDAC
4
Novel Antibody-Drug Conjugate Eliminates Residual Cancer Cells in Majority of Patients With B-Cell ALL
5